Janux Therapeutics, Inc. upgraded to Strong Buy: below cash value, strong runway, TRACTr progress, Merck/BMY milestones.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results